Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer

Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer.

The Swiss consumer-goods company said Monday that it will receive milestone payments and royalties from Stallergenes Greer. The deal was closed upon signing, Nestle said. The sale allows Nestle's health-science operations to focus on its core strengths and key growth drivers, the unit's Chief Executive Greg Behar said.

Nestle last year said that it would conduct a strategic review of Palforzia after a slower-than-expected adoption by patients and healthcare professionals.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Nestle divests peanut allergy business Palforzia By ReutersNestle divests peanut allergy business Palforzia
Fonte: Investingcom - 🏆 450. / 53 Consulte Mais informação »

Nestle divests peanut allergy business PalforziaNestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review of the division.
Fonte: Reuters - 🏆 2. / 97 Consulte Mais informação »